These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 11434406)

  • 1. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
    Kalb R; Trautmann-Sponsel RD; Kieser M
    Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
    Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M
    Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
    Lecrubier Y; Clerc G; Didi R; Kieser M
    Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
    Kasper S; Anghelescu IG; Szegedi A; Dienel A; Kieser M
    BMC Med; 2006 Jun; 4():14. PubMed ID: 16796730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities.
    Laakmann G; Dienel A; Kieser M
    Phytomedicine; 1998 Dec; 5(6):435-42. PubMed ID: 23196026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.
    Randløv C; Mehlsen J; Thomsen CF; Hedman C; von Fircks H; Winther K
    Phytomedicine; 2006 Mar; 13(4):215-21. PubMed ID: 16423519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G; Schüle C; Baghai T; Kieser M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials.
    Kasper S; Dienel A
    Psychopharmacology (Berl); 2002 Nov; 164(3):301-8. PubMed ID: 12424554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.
    Mannel M; Kuhn U; Schmidt U; Ploch M; Murck H
    J Psychiatr Res; 2010 Sep; 44(12):760-7. PubMed ID: 20181361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
    Volz HP; Murck H; Kasper S; Möller HJ
    Psychopharmacology (Berl); 2002 Nov; 164(3):294-300. PubMed ID: 12424553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10.
    Vorbach EU; Arnoldt KH; Hübner WD
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():81-5. PubMed ID: 9342765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.
    Singer A; Schmidt M; Hauke W; Stade K
    Phytomedicine; 2011 Jun; 18(8-9):739-42. PubMed ID: 21514125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
    Brenner R; Azbel V; Madhusoodanan S; Pawlowska M
    Clin Ther; 2000 Apr; 22(4):411-9. PubMed ID: 10823363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
    Brattström A
    Phytomedicine; 2009 Apr; 16(4):277-83. PubMed ID: 19299116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting stable treatment response in patients with major depression treated with hypericum extract WS 5570/5572.
    Kieser M; Szegedi A
    Pharmacopsychiatry; 2005 Sep; 38(5):194-200. PubMed ID: 16189745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression.
    Kasper S; Caraci F; Forti B; Drago F; Aguglia E
    Eur Neuropsychopharmacol; 2010 Nov; 20(11):747-65. PubMed ID: 20708905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.